N@N

Geoff Meacham Maintained (AMGN) at Hold with Decreased Target to $180 on, Apr 5th, 2018

Geoff Meacham of Barclays, Maintained "Amgen Inc." (AMGN) at Hold with Decreased Target from $190 to $180 on, Apr 5th, 2018.

Geoff has made no other calls on AMGN in the last 4 months.

There are 7 other peers that have a rating on AMGN. Out of the 7 peers that are also analyzing AMGN, 4 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Steve Chesney of "Atlantic Equities" Downgraded from Buy to Hold on, Monday, February 5th, 2018
• Ian Somaiya of "BMO Capital" Maintained at Hold with Increased Target to $202 on, Friday, February 2nd, 2018
• Alethia Young of "Credit Suisse" Maintained at Hold with Increased Target to $194 on, Friday, February 2nd, 2018
• Cory Kasimov of "JP Morgan" Maintained at Hold with Increased Target to $189 on, Wednesday, January 24th, 2018

These are the ratings of the 3 analyists that currently disagree with Geoff

---

• Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $196 on, Friday, February 2nd, 2018
• Christopher Raymond of "Piper Sandler" Maintained at Buy with Decreased Target to $190 on, Friday, February 2nd, 2018
• David Toung of "Argus Research" Upgraded from Hold to Strong Buy and Held Target at $220 on, Tuesday, January 23rd, 2018

Contributing Sources

---